// App-Quantinova.ai

: Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Researchers

Presenter

  • Sara Ovejero-Merino

Principal Investigators

  • Julie Devin

  • Tatiana Cañeque

  • Laura Alibert

  • Guilhem Requirand

  • Nicolas Robert

  • Alizee Steer

  • Amelie Machura

  • Christophe Hirtz

  • Angelique Bruyer

  • Laure Vincent

  • Guillaume Cartron

  • Charles Herbaux

  • Raphael Rodriguez

  • Caroline Bret

  • Jerome Moreaux

Medical Centers

  • Department of Hematology, Montpellier University Hospital, Montpellier, France

  • University of Montpellier, UFR Medecine, Montpellier, France

  • Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France

  • CHU Montpellier, Laboratory of Biochemistry - Clinical Proteomic, Montpellier, France

  • Institute of Human Genetics, Montpellier, FRA

  • Institute of Human Genetics, UMR CNRS-UM, Montpellier, France

  • Institut Curie, PARIS, France

  • DiagTec, Montpellier, France

  • CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France

  • UFR Médecine, Université Montpellier, Montpellier, France

  • Institut Universitaire de France, Paris, France

  • Department of Biological Hematology, CHU Montpellier, Montpellier, France

  • University of Montpellier, Paris, France

  • CHU de Montpellier, Montpellier, France

  • Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Hematological malignancies

  • Acute myelocytic leukemia

  • High-risk myeloma

  • Multiple Myeloma

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Interferon regulatory factor 4

  • Cyclin D1

  • Granulin precursor

  • Total triiodothyronine

  • DNA methylation

Drug/Treatment

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • salinomycin

  • Bortezomib

  • Sandolase

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved